Lv1
32 积分 2026-01-04 加入
Pathogenic changes in group 2 innate lymphoid cells (ILC2s) in a steroid-insensitive asthma model of mice
2天前
已完结
Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities
8天前
已完结
Transcription factor RORα is critical for nuocyte development
14天前
已完结
Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161
14天前
已完结
Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials
16天前
已完结
Dupilumab reduces inflammation and restores the skin barrier in patients with atopic dermatitis
17天前
已完结
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
17天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
17天前
已完结
Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma
19天前
已完结
Innate and Adaptive Immunity: ILC2 and Th2 Cells in Upper and Lower Airway Allergic Diseases
20天前
已完结
皖公网安备34019202002308
